“EMFs represent promising, minimally invasive control modalities for next-generation gene- and cell-based therapies.”
Using mT fields in the 0.1-1 kHz frequency range with nanoparticles to generate reactive oxygen species.
From Department of Biosystems Science and Engineering, ETH Zurich in Basel. open access.
“[O]ur work highlights the use of weak EMFs (up to 21 mT), much weaker than those used in MRI scanners (in the tesla range), promising safety in clinical use. This level of EMFs can be achieved by a single induction coil with a fixed coil structure and input parameters (akin to wireless phone chargers), and tuned by adjusting a single parameter, stimulation time, avoiding the need for complex software or electronic implants. We believe that this kind of interface between programmable electronic devices and genetic therapies has the potential to dramatically streamline the treatment regimen for patients with chronic diseases.”
https://microwavenews.com/papers/wireless-control-transgene-expression
